Spine Surgery Devices Market in Europe: Jsbmarketresearch

Europe Spine Surgery Devices Market by Product, by End-User, by Geography – Analysis & Forecast to 2019

Released On 16th December 2015

The European spine surgery devices market is expected to reach $2,993.6 million by 2019, at a CAGR of 7.3% from 2014 to 2019. This is mainly due to the increasing incidences of spinal deformities such as disc compression amongst the aging population in the European region, and the popularity of non-fusion devices such as artificial spinal disc and nucleus. The increasing demand from the aging population, along with the advancement in medical technology (minimally invasive techniques and biologics) is driving the demand for the spine surgery devices market.

In this report, the spine surgery devices market is broadly segmented into four classes such as fusion, non-fusion, spinal decompression and spine biologics. Fusion category can be divided into spine fusion and fixation and spinal bone stimulators. Non-fusion segment consists of motion preservation technologies such as dynamic stabilization, artificial discs, annual repair and nucleus replacement. Vertebral compression factures treatment category includes market for vertebroplasty and kyphoplasty kits. Spinal decompression segment consists of niche markets such as corpectomy, disectomy, foraminotomy / forminectomy and laminotomy / laminectomy. Allogarfts, bone morphonenetic proteins, demineralised bone matrix, bone substitutes and machined bones, together contribute to overall category of spine biologics. 

The Europe Spine Surgery Devices Market is a competitive market with a number of market players. As of 2014, the Europe Spine Surgery Devices market is estimated to be dominated by Stryker Corporation (U.S.), DePuy Synthes Companies of Johnson & Johnson (U.S.), Zimmer Holdings, Inc. (U.S.), Smith & Nephew Plc (U.K.), Tornier, Inc. (France) and Biomet, Inc. (U.S.). New product launches, mergers & acquisition, agreements, approvals are the major...